Czeslaw Radziejewski
AbbVie (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Protein purification and stability, Angiogenesis and VEGF in Cancer, Nerve injury and regeneration, Glycosylation and Glycoproteins Research
Most-Cited Works
- → Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis(1997)3,531 cited
- → Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning(1996)1,977 cited
- → VEGF-Trap: A VEGF blocker with potent antitumor effects(2002)1,671 cited
- → VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment(2004)1,011 cited
- → trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor(1991)838 cited
- → The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons(1992)746 cited
- → Agrin Acts via a MuSK Receptor Complex(1996)657 cited
- → An Orphan Receptor Tyrosine Kinase Family Whose Members Serve as Nonintegrin Collagen Receptors(1997)523 cited
- → Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2(1998)371 cited
- → Cytokine traps: multi-component, high-affinity blockers of cytokine action(2002)360 cited